Alliance Pharma Plc Ord 1P is listed on the London Stock Exchange trading with ticker code APH.L, and is part of the Medicine and Biotech Research sector. It has a market capitalisation of £34,203m, with approximately 518m shares in issue.
Alliance Pharma Plc, officially known as Alliance Pharma Plc Ord 1P was formed in June of 2001, making the company eighteen years old. The company filed its latest accounts on 31st December 2014, showing a turnover of approximately 43.54 million GBX with gross profits of 25.04 million, or 0.0483 per issued share, and a pre-tax profit margin of 23.33%. Alliance Pharma Plc currently has 7 directors, and has had 16 previous directors over the last 18 years. In the last set of accounts produced by Grant Thornton Uk Llp, the company showed 6.00 million paid in salaries to the 74 staff (average wage of 81 thousand), with the directors receiving an average 135 thousand each. In the accounts filed in 2014, the company paid 2398000 in dividends, or 0.0046 per share.
Alliance Pharma Plc is in the Medicine and Biotech Research sector.
Alliance Pharma Plc is in the MID 300 index.
|Real Estate Investors Plc (RLE.L)|
|Rockhopper Exploration Plc (RKH.L)|
|E-therapeutics Plc (ETX.L)|
|Ashley (Laura) Holdings Plc (ALY.L)|
|Steppe Cement Ltd (STCM.L)|
|Shares in Issue||518m|
|52 Week High||0.00|
|52 Week Low||0.00|